s6y
Company name or ticker
Search
Oruka Therapeutics, Inc.
4
Quinlan Paul T: Statement of changes in beneficial ownership of securities
Filed
Monday, September 21, 2026
Period
Sep 21, 2026
Accession number
0000907654-26-000100
Documents
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4
On sec.gov
Filing index
All files
Complete submission text
SGML header